Can I Take Glycine With Sermorelin?

  • Interaction status / None known
  • Sermorelin / 29-amino-acid GHRH analogue that prompts the pituitary to release growth hormone, not growth hormone itself [5]
  • Sermorelin status / Geref discontinued in 2008, approvals withdrawn in 2009; products sold today are compounded and not FDA-approved [3][4]
  • Glycine / Non-essential amino acid sold over the counter as a supplement [6][7]
  • Glycine interaction record / Clozapine trials only, at 30 to 60 g per day [1][2]
  • Sport / WADA prohibits sermorelin at all times, in and out of competition [10]

What sermorelin is

Sermorelin acetate is a 29-amino-acid analogue of human growth hormone-releasing hormone (GHRH), the shortest synthetic peptide with GHRH's full biological activity. It is not growth hormone [5]. It acts on the pituitary's GHRH receptor so the body releases its own growth hormone; after an intravenous dose in healthy men sermorelin was eliminated quickly, yet growth hormone stayed raised for about 3 hours [5][11].

Sermorelin was FDA-approved as Geref for two uses only: a diagnostic test of the pituitary's ability to secrete growth hormone (NDA 019863, approved December 28, 1990) and treatment of idiopathic growth hormone deficiency in children with growth failure (NDA 020443, approved September 26, 1997) [3]. It was not approved for adults, anti-aging, weight loss or athletic performance [3]. The manufacturer discontinued both products in 2008, and FDA withdrew the two approvals effective June 18, 2009. In March 2013 FDA determined that Geref had not been withdrawn from sale for reasons of safety or effectiveness [3][12].

Sermorelin sold in the United States today is compounded, not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed [4]. Sermorelin acetate does not appear on FDA's list of bulk substances that may present significant safety risks when compounded [13]; it sits in category 1, under evaluation, on FDA's list of substances nominated for large registered compounding facilities [14]. It is also named on WADA's Prohibited List in S2.2.4 as a growth hormone releasing factor, banned at all times in and out of competition [10][15].

What glycine is

Glycine is a non-essential amino acid. The liver and kidneys use glycine, arginine and methionine to make about 1 g of creatine a day, and oral glycine is sold over the counter as a dietary supplement [6][7]. Drugs@FDA lists glycine in approved prescription irrigation and injectable products, such as glycine 1.5% irrigation solution (NDA 016784, 1978) and parenteral amino acid mixtures [6][7].

Can you take them together?

No interaction between glycine and sermorelin has been reported, and human interaction studies of glycine with other common medicines, such as blood pressure, diabetes or hormone therapies, were not found either [9]. An unreported interaction is not the same thing as a tested-safe combination.

The one medicine glycine has a documented signal with is clozapine, at doses far above supplement range. In a 19-patient trial, glycine 30 g a day for 12 weeks added to clozapine did not reduce symptoms, while the patients taking clozapine alone had a 35% fall in positive symptoms; the authors suggested glycine may interfere with clozapine's effect [1]. A second trial of 30 adults taking 60 g a day for 8 weeks found no significant change in symptoms or thinking and no clinically significant worsening [2]. Those doses are 10 to 20 times the 3 g used in the sleep study [9][1][2].

What the glycine sleep study measured

In one study, healthy volunteers whose sleep was cut by about 25% for three consecutive nights took 3 g of glycine or placebo before bed. Next-day fatigue fell on a visual analog scale, sleepiness tended to fall, psychomotor vigilance improved, and plasma melatonin was unchanged [9]. This was not a trial in people with insomnia.

The tolerability reports for glycine come from trials of GlyNAC, a glycine plus N-acetylcysteine combination. In a 16-week trial of 24 older adults, 12 received GlyNAC (1:1) and 12 received an alanine placebo, and the authors described GlyNAC as safe and well tolerated [16]. A separate 2-week dose trial gave GlyNAC at 2.4, 4.8 or 7.2 g a day total to 114 healthy older adults and likewise described it as safe and well tolerated [17]. Neither report gives a side-effect list for glycine alone [16][17].

Doses and results from the sermorelin studies

No sermorelin product is currently FDA-approved, so there is no current approved dose [3][4]. In the pediatric program the dose was 30 micrograms per kg once daily subcutaneously at bedtime; in older men it was 0.5 mg or 1 mg subcutaneously twice daily for 14 days [8][18]. These are study doses, not recommendations.

In the 1-year pediatric study, 110 previously untreated children were treated (86 evaluable). Mean height velocity rose from 4.1 cm a year at baseline to 8.0 at 6 months and 7.2 at 12 months. No adverse changes appeared in general biochemistry or hormone tests, fasting glucose did not change, IGF-I was not excessively raised, and sermorelin was well tolerated overall [8]. The older-men study was much smaller: 10 men aged about 68 took both doses in random order, and at 1 mg twice daily their 24-hour growth hormone and IGF-I rose to levels not significantly different from 9 young men. That was a short physiology study, not a trial of clinical benefit [18].

Can I take glycine with sermorelin?
We found no study testing glycine with sermorelin, so their interaction has not been measured. Human interaction studies of glycine with blood pressure, diabetes or hormone medicines were not found either [9]. Glycine is an over-the-counter supplement and sermorelin is a compounded peptide [4].
What did the glycine sleep study measure?
Healthy volunteers with sleep cut by about 25% for three nights took 3 g of glycine or placebo before bed. The study reported next-day fatigue, sleepiness, psychomotor vigilance and plasma melatonin [9]. Sermorelin's growth hormone and IGF-I effects were measured in separate studies in children and in older men [8][18].
What glycine doses have been studied?
3 g before bedtime for three nights in sleep-restricted volunteers [9]; glycine plus N-acetylcysteine at 2.4, 4.8 or 7.2 g a day total for two weeks in 114 older adults [17]; and 30 to 60 g a day in schizophrenia trials [1][2]. These are study doses, not recommended doses.
Does sermorelin have an FDA-approved label?
Not anymore. Geref's two applications were withdrawn effective June 18, 2009, and FDA later determined it had not been withdrawn for safety or effectiveness reasons [3]. Sermorelin sold today is compounded, and FDA does not review compounded drugs for safety, effectiveness or quality before marketing [4].
Does glycine have side effects?
The tolerability reports come from GlyNAC trials, not glycine alone. In a 16-week trial of 24 older adults and a 2-week dose trial in 114 healthy older adults, GlyNAC was described as safe and well tolerated [16][17]. Neither report gives a side-effect list for glycine alone.
Is sermorelin allowed in sport?
No. WADA's 2026 Prohibited List names sermorelin in S2.2.4, growth hormone releasing factors, prohibited at all times in and out of competition, and the 2027 List names it too [10][15].
Show all 18 referencesHide references
  1. Potkin SG, Jin Y, Bunney BG, Costa J, Gulasekaram B. Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia. Am J Psychiatry. 1999;156(1):145-7.
  2. Evins AE, Fitzgerald SM, Wine L, Rosselli R, Goff DC. Placebo-controlled trial of glycine added to clozapine in schizophrenia. Am J Psychiatry. 2000;157(5):826-8.
  3. Federal Register :: Request Access.
  4. Official web page.
  5. Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
  6. National Institutes of Health.
  7. Drugs@FDA: FDA-Approved Drugs.
  8. Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, et al. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. J Clin Endocrinol Metab. 1996;81(3):1189-96.
  9. Bannai M, Kawai N, Ono K, Nakahara K, Murakami N. The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. Front Neurol. 2012;3:61.
  10. World Anti-Doping Agency.
  11. Wilton P, Chardet Y, Danielson K, Widlund L, Gunnarsson R. Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration. Acta Paediatr Suppl. 1993;388:10-5.
  12. U.S. Food and Drug Administration.
  13. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
  14. U.S. Food and Drug Administration.
  15. World Anti-Doping Agency.
  16. Kumar P, Liu C, Suliburk J, Hsu JW, Muthupillai R, Jahoor F, et al. Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci. 2023;78(1):75-89.
  17. Lizzo G, Migliavacca E, Lamers D, Frézal A, Corthesy J, Vinyes-Parès G, et al. A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage. Front Aging. 2022;3:852569.
  18. Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992;75(2):530-5.
Sermorelin glycine: evidence summary chart
Image: HealthRX.com. Full sermorelin glycine guide and sources at healthrx.com/supplements-sermorelin.